Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Brittany Runde

Physician Assistant Charlotte, NC Physician Assistant

NPI 1639731698 CMS profile 10513555

416 McCullough Dr Ste 100, Charlotte, NC 28262

Open in the dashboard

General payments

$12,564

744 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brittany Runde of Charlotte, NC is reported in the CMS Open Payments database as having received $12,564 across 744 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,754 104
2024 General $2,916 178
2023 General $2,834 158
2022 General $2,618 147
2021 General $2,441 157

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brittany Runde
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Brittany Runde were reported at $1,754. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Brittany Runde Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,441 $132 $37–$438 $132
2022 $2,618 $155 $48–$522 $149
2023 $2,834 $167 $52–$557 $160
2024 $2,916 $178 $55–$600 $164
2025 $1,754 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,025 111 payments
  2. ITI, Inc. $1,190 67 payments
  3. Otsuka America Pharmaceutical, Inc. $1,052 60 payments
  4. Teva Pharmaceuticals USA, Inc. $895 60 payments
  5. Neurocrine Biosciences, Inc. $891 56 payments
  6. Ironshore Pharmaceuticals Inc. $872 51 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $872 72 payments
  8. Supernus Pharmaceuticals, Inc. $747 40 payments
  9. Alkermes, Inc. $729 48 payments
  10. Sunovion Pharmaceuticals Inc. $639 35 payments
  11. Other $2,652 144 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $12,428 741 payments
  2. Education $136 3 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR $1,658 98 payments
  2. CAPLYTA $1,054 61 payments
  3. TRINTELLIX $787 67 payments
  4. ARISTADA Cns $708 47 payments
  5. ARISTADA Cns $708 47 payments
  6. LYBALVI $674 45 payments
  7. REXULTI $647 40 payments
  8. LATUDA $639 35 payments
  9. INGREZZA $617 40 payments
  10. JORNAY PM $599 32 payments
  11. Other $7,700 444 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

744 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record